NeuroOne Medical Technologies Corporation Proceeds from Issuance of Unsecured Debt
NeuroOne Medical Technologies Corporation (NMTC) reported Proceeds from Issuance of Unsecured Debt of $245.00 thousand for the 9-month period ending 2019-06-30, per its 10-Q filed 2020-08-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfUnsecuredDebt · last filed 2020-08-13
- NeuroOne Medical Technologies Corporation proceeds from issuance of unsecured debt for the quarter ending 2019-06-30 was $0.00.
- NeuroOne Medical Technologies Corporation proceeds from issuance of unsecured debt for the quarter ending 2019-03-31 was $0.00.
- NeuroOne Medical Technologies Corporation proceeds from issuance of unsecured debt for the quarter ending 2018-12-31 was $245.00K.
| Period end | Proceeds from Issuance of Unsecured Debt 3 month | Proceeds from Issuance of Unsecured Debt 6 month | Proceeds from Issuance of Unsecured Debt 9 month |
|---|---|---|---|
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | $0.00 derived: sum of 2 quarters · filed 2020-08-13 | $245.00K 10-Q · filed 2020-08-13 |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-14 | $245.00K 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $245.00K 10-Q · filed 2020-02-14 | ||
| 2018-09-30 | $5.00M 10-KT · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |